Touyun Biotech Group Ltd 2023 AR2
The report highlights Touyun Biotech Group Limited's financial and sustainability performance for the fiscal year 2023. The company expanded its Chlamydomonas reinhardtii product line, launching low glycemic index food offerings and penetrating over 2,000 retail outlets in China. On the environmental front, the group reduced its total energy consumption to 62,834.78 GJ and greenhouse gas emissions to 7,546.70 tCO2e. Additionally, the company maintained its commitment to occupational health and safety, reporting zero work-related fatalities and injuries in 2023.
Company: Touyun Biotech Group Ltd
Sector: Materials
Country: Hong Kong
Year: 2023
Type: AR2
Pages: 163
Touyun Biotech Group Ltd
Annual Report
The report highlights Touyun Biotech Group Limited's financial and sustainability performance for the fiscal year 2023. The company expanded its Chlamydomonas reinhardtii product line, launching low glycemic index food offerings and penetrating over 2,000 retail outlets in China. On the environmental front, the group reduced its total energy consumption to 62,834.78 GJ and greenhouse gas emissions to 7,546.70 tCO2e. Additionally, the company maintained its commitment to occupational health and safety, reporting zero work-related fatalities and injuries in 2023.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Workplace Fatalities
Employees